中关村：下属公司盐酸丁螺环酮片一致性评价申请获受理

Core Viewpoint - Beijing Huasu Pharmaceutical Co., Ltd., a subsidiary of Zhongguancun, has received the Acceptance Notification from the National Medical Products Administration for the consistency evaluation application of the generic drug Buprenorphine Hydrochloride Tablets (specifications: 5mg, 10mg) [1] Group 1 - Buprenorphine is the first non-benzodiazepine anxiolytic drug [1] - In China, a total of four companies, including Beijing Huasu, have approved generic drugs for market entry, with two companies having passed the consistency evaluation for quality and efficacy of generic drugs [1]